PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Immune system fights infection with performance enhancement

2013-09-23
(Press-News.org) Researchers in Melbourne, Australia, have found that even our immune system is subject to performance enhancement, with our bodies giving immune cells the boost they need to ensure the best team is selected to fight infections.

The discovery could help in developing new treatments for blood diseases such as leukaemia and autoimmune diseases in which the body attacks its own tissues, such as in diabetes or rheumatoid arthritis. It could also be used to enhance immune response to HIV and other chronic infections.

The finding, by researchers at the Walter and Eliza Hall Institute, builds on the 55-year-old theory of 'clonal selection' proposed by Australian Nobel Laureate and former institute director Sir Macfarlane Burnet. The theory revolutionised scientists' understanding of the immune system and how it functioned.

Dr Axel Kallies, Mr Kevin Man and colleagues from the institute's Molecular Immunology division led the research, which was published today in the journal Nature Immunology.

Burnet's theory of clonal selection proposed a new model of how the immune system recognised and fought foreign invaders, stating that each immune cell was programmed to recognise a specific infectious agent. Only when the right cell came into contact with an invader would it be activated and stimulated to 'clone' itself, generating large numbers of identical cells to fight the infection."

Studying a type of immune cell called killer T cells, Dr Kallies and his research team showed how the body identified which cells were the most capable of fighting a particular infection. Killer T cells are responsible for killing virus- or bacteria-infected cells, tumour cells and other damaged cells in the body.

"We found that a protein called IRF4 is activated in killer T cell 'clones' that are best equipped to recognise and fight an infection," Dr Kallies said. "Burnet's clonal selection theory tells us that the best T cell clones are selected by the immune system and produced in large numbers but, until now, we didn't know how this was regulated and what happened at the molecular level. We discovered that IRF4 controls the mass production of 'elite' killer T cells, as well as ensuring their survival and enhancing their performance by allowing them to take up large amounts of sugar and other nutrients."

The research team found that IRF4 was produced at different levels depending on how well the killer T cell recognised and bound infected cells. "IRF4 was produced at the highest levels in cells that were the best at recognising the foreign invader," Dr Kallies said. "This is how the immune system guarantees that the best killer T cells survive, producing an 'army of clones' that maintain their killer function to fight the infection. Without sufficient IRF4, the immune system fails to mount a productive immune response."

Dr Kallies said IRF4 was already being investigated by pharmaceutical companies as a potential therapeutic target. "We are slowly peeling back the layers of how immune cells develop, become activated and function," Dr Kallies said. "Targeting the IRF4 pathway could help us to control immune cells. For example, blocking the pathway to diminish proliferation of immune cells when they are out of control, as happens in blood cancers such as leukaemia or in autoimmunity. We could also enhance the activation of IRF4 to rescue T cell clones that are not functional, as a way of boosting the immune response to overwhelming infections such as HIV."



INFORMATION:

The research was funded by the Australian National Health and Medical Research Council, Australian Research Council and the Victorian Government.



ELSE PRESS RELEASES FROM THIS DATE:

Climate change nothing new in Oz

2013-09-23
While we grapple with the impact of climate change, archaeologists suggest we spare a thought for Aboriginal Australians who had to cope with the last ice age. "The period scientists call the Last Glacial Maximum, or LGM for short, is the most significant climatic event ever faced by humans on this continent," Associate Professor Sean Ulm from James Cook University in Cairns said. Research recently published in the Journal of Archaeological Science sheds new light on the ways Aboriginal civilisation met the challenges of extreme climate change during the Last Glacial ...

Richness mapping and prediction of amphibians in Southern and Central China

2013-09-23
Systematic conservation planning is a multiple-objective process. Identification of important areas and species with high conservation priority is two of the research objectives. China is one of mega-biodiversity countries of the world. Along with rapid economic development and environmental degeneration, native and endemic species of China are confronting growing threats in the last two decades. It is an urgent agenda to set up relevant conservation policies, researches and decision supports so as to better reduce extinction risks of vertebrate animals of China. Amphibians ...

Encouraging outcomes for pediatric brain tumor patients treated with proton therapy

2013-09-23
Atlanta, September 22, 2013—When used to treat pediatric patients with intracranial malignant tumors, proton therapy may limit the toxicity of radiation therapy while preserving tumor control, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting. Typically, central nervous system malignancies are treated with surgical resection and post-operative radiation therapy. Proton therapy, an external beam radiation therapy in which protons deliver precise radiation doses to a tumor, offers significant sparing of ...

Sulfasalazine does not reduce diarrhea for patients receiving pelvic radiation therapy

2013-09-23
Atlanta, September 22, 2013—Patients receiving radiotherapy (RT) for cancers in the pelvic region can experience diarrhea, a negative side effect of radiation treatment. Sulfasalazine, an oral tablet used to treat inflammation of the bowels, had been shown in a past trial of 31 patients to decrease diarrhea during pelvic RT (Killic 2001). Sulfasalazine does not reduce diarrhea, according to research presented today at the American Society of Radiation Oncology's (ASTRO's) 55th Annual Meeting. The study also determined that the medication may be associated with a higher ...

Cisplatin combined with high-dose brachytherapy for advanced cervical cancer may be more beneficial

2013-09-23
Atlanta, September 22, 2013 — Adding the chemotherapy drug cisplatin to a treatment plan of radiation therapy (RT) and high-dose-rate brachytherapy (HDRB) for stage IIIB cervical cancer is beneficial, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting. The study also indicated that the combined treatments produced acceptable levels of toxicity. The randomized, controlled trial studied a total of 147 women in Brazil with stage IIIB squamous cell cervical cancer. A stage IIIB classification indicates that ...

Proton therapy is a cost-effective treatment for pediatric brain tumor patients

2013-09-23
Atlanta, September 22, 2013—Proton therapy, an external beam radiotherapy in which protons deliver precise radiation doses to a tumor and spare healthy organs and tissues, is cost-effective in treating medulloblastomas, fast-growing brain tumors that mainly affect children, when compared to standard photon radiation therapy, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting. The study used a first-order Monte Carlo simulation model to examine a population of 18-year old survivors of medulloblastoma brain ...

Adult cancer patients younger than 50 with limited brain mets have improved OS after SRS alone

2013-09-23
Atlanta, September 22, 2013—When treated with stereotactic radiosurgery (SRS), that is not combined with whole brain radiotherapy (WBRT), adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting. Younger patients (under 50 years old) were also found to be at no greater risk of new brain metastases developing despite omission of WBRT. A highly advanced brain cancer treatment, stereotactic radiosurgery (SRS) utilizes ...

ASTRO/AUA joint guideline for RT after prostatectomy highlighted at ASTRO Annual Meeting

2013-09-23
Atlanta, September 22, 2013 – The American Society for Radiation Oncology (ASTRO) will highlight the recently published Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline during ASTRO's 55th Annual Meeting, September 22-25, 2013, in Atlanta. The guideline focuses on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence, and is a joint effort between ASTRO and the American Urological Association (AUA). The 81-page document represents an intensive collaboration among experts in the radiation oncology ...

'Green future' development: Top 10 priorities for emerging economy countries

2013-09-23
Investments in green energy, education, networking opportunities and research top a list of 10 priorities for countries looking to move up the world's financial ranks, according to a leading US expert in innovation, creativity, entrepreneurship and economic growth. Jerry Hultin, Senior Presidential Fellow of New York University, and President Emeritus of the Polytechnic Institute of NYU, says investments in life-long education and entrepreneurial spirit are the primary keys to a country's economic breakthrough. Mr. Hultin, also a former US Secretary of the Navy, who ...

Booster dose of new meningitis vaccine may be beneficial

2013-09-23
A study of 4CMenB, a new vaccine to protect against meningitis B bacteria (which can cause potentially fatal bacterial meningitis in children), shows that waning immunity induced by infant vaccination can be overcome by a booster dose at 40 months of age, according to a clinical trial published in CMAJ (Canadian Medical Association Journal). The 4CMenB vaccine, an important breakthrough in the fight against childhood meningitis, was recently licensed in Europe and is being considered for approval in Canada and elsewhere. However, although it is known that immunizing infants ...

LAST 30 PRESS RELEASES:

Exercise as an anti-ageing intervention to avoid detrimental impact of mental fatigue

UMass Amherst Nursing Professor Emerita honored as ‘Living Legend’

New guidelines aim to improve cystic fibrosis screening

Picky eaters by day, buffet by night: Butterfly, moth diets sync to plant aromas

Pennington Biomedical’s Dr. Leanne Redman honored with the E. V. McCollum Award from the American Society for Nutrition

CCNY physicists uncover electronic interactions mediated via spin waves

Researchers’ 3D-printing formula may transform future of foam

Nurture more important than nature for robotic hand

Drug-delivering aptamers target leukemia stem cells for one-two knockout punch

New study finds that over 95% of sponsored influencer posts on Twitter were not disclosed

New sea grant report helps great lakes fish farmers navigate aquaculture regulations

Strain “trick” improves perovskite solar cells’ efficiency

How GPS helps older drivers stay on the roads

Estrogen and progesterone stimulate the body to make opioids

Dancing with the cells – how acoustically levitating a diamond led to a breakthrough in biotech automation

Machine learning helps construct an evolutionary timeline of bacteria

Cellular regulator of mRNA vaccine revealed... offering new therapeutic options

Animal behavioral diversity at risk in the face of declining biodiversity

Finding their way: GPS ignites independence in older adult drivers

Antibiotic resistance among key bacterial species plateaus over time

‘Some insects are declining but what’s happening to the other 99%?’

Powerful new software platform could reshape biomedical research by making data analysis more accessible

Revealing capillaries and cells in living organs with ultrasound

American College of Physicians awards $260,000 in grants to address equity challenges in obesity care

Researchers from MARE ULisboa discover that the European catfish, an invasive species in Portugal, has a prolonged breeding season, enhancing its invasive potential

Rakesh K. Jain, PhD, FAACR, honored with the 2025 AACR Award for Lifetime Achievement in Cancer Research

Solar cells made of moon dust could power future space exploration

Deporting immigrants may further shrink the health care workforce

Border region emergency medical services in migrant emergency care

Resident physician intentions regarding unionization

[Press-News.org] Immune system fights infection with performance enhancement